Skip to main content
. 2022 Mar 9;9:847259. doi: 10.3389/fcvm.2022.847259

Table 1B.

Baseline clinical characteristics of patients with BAAS for BE-THV, implanted with BE or non-borderline SE-THV.

Smaller borderline-BE-THV (n = 22) Larger borderline-BE-THV (n = 102) Non-borderline SE-THV (n = 96) p-value* p-value#
Female (%) 10 (45.4) 24 (23.5) 61 (63.5) 0.06 1.40e-08
DM (%) 10 (45.4) 43 (42.1) 43 (44.8) 1 0.24
BMI kg/m2 28.6 ± 3.7
[27.4, 4.6]
27.5 ± 4.4
[26.9, 5.4]
28 ± 4.9
[27.8, 6.9]
0.12 0.23
STS score 4 ± 4.5
[2.6, 2.1]
3.4 ± 2.25
[2.7, 2.1]
4.2 ± 2.4
[3.6, 2.6]
0.36 0.003
PR interval (ms) 185 ± 60
[189, 33.5]
181 ± 34
[182, 48.5]
174 ± 34.18
[171, 36.5]
0.42 0.12
QRS duration (ms) 135 ± 30
[148, 44]
121 ± 33
[107, 59]
106.9 ± 28
[100, 32]
0.11 0.05
NYHA functional class: 0.18 0.1
I 1 (4.5) 0 (0) 2 (2.2)
II 5 (22.7) 22 (21.5) 29 (31.5)
III 12 (54.5) 61 (59.8) 44 (47.8)
IV 4 (18) 13 (12.7) 17 (18.5)

Values are mean ± SD or [median, interquartile range (IQR)] or n (%). DM, diabetes mellitus; BMI, body mass index; STS score, the society of thoracic surgeons scores; NYHA, New York Heart Association; SE, self-expandable; BE, balloon-expandable; THV, transcatheter heart valve.

*

Smaller borderline-BE-THV vs. larger borderline-BE-THV.

#

Larger borderline-BE-THV vs. non-borderline-SE.